Likewise, MetS is usually associated with increased levels of inflammatory mediators such as C reactive protein (PCR), interleukin-6 (IL-6), or tumoral necrosis factor alpha (TNF-α) [14], both in the plasma and at the tissue level, so molecules with anti-inflammatory effects may also be potentially useful. The gene discussed is IL6; the disease is metabolic syndrome.